PHIO Earnings

Quarterly EPS
$-1.54
Q3 2024
$0.00
Q4 2024
$-0.41
Q1 2025
$-0.45
Q2 2025
$-0.44
Q3 2025
$-0.25
Q4 2025
$-0.34
Q1 2026
$-0.36
Q2 2026
Latest RevenueN/A
Latest Net Income-4138000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.360-4138000+20.0%
Q1 2026-$0.340-4003000+17.1%
Q4 2025-$0.250-2371000
Q3 2025-$0.440-2392000+71.4%
Q2 2025-$0.450-2166000+87.6%
Q1 2025-$0.410-1769000+12.8%
Q4 20240-1626000
Q3 2024-$1.540-1524000+85.0%
Q2 2024-$3.620-1846000
Q1 2024-$0.470-2154000
Q4 2023-$2.530-1895000
Q3 2023-$10.250-2780000
Phio Pharmaceuticals (PHIO) — Earnings